1. Cost effectiveness of oncotype Dx for early stage breast cancer; under National Health Insurance. (April 2018) Authors: Kim, Y.; Kim, K.E.; Ju, Y.W.; Lee, E.; Lee, H.B.; Moon, H.G.; Noh, D.Y.; Han, W. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Is necessary neoadjuvant chemotherapy in metaplastic breast cancer?. (April 2018) Authors: Kim, K.E.; Han, W.; Lee, H.B.; Lee, E.S.; Kim, Y.; Park, J.H.; Ju, Y.W.; Moon, H.G.; Noh, D.Y. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic influence of korean public medical insurance system on breast cancer patients. Issue 2 (February 2019) Authors: Hwang, K.T.; Ju, Y.W.; Kim, Y.A.; Kim, J.; Oh, S.; Jung, J.; Chai, Y.J.; Choi, I.S.; Oh, S.W. Journal: European journal of surgical oncology Issue: Volume 45:Issue 2(2019) Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗